Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: Different molecular mechanisms for cis-9, trans-11, and trans-10 cis-12 isomers

Carcinogenesis

Volumn 25, Issue 7, 2004, Pages 1185-1191

  Ochoa, Julio J ^a   Farquharson, Andrew J ^b   Grant, Ian ^b,c   Moffat, L E ^d   Heys, Steven D ^e   Wahle, Klaus W J ^b,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

^d NHS GRAMPIAN   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME; LINOLEIC ACID; MESSENGER RNA; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P21;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL VIABILITY; CIS TRANS ISOMERISM; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; MITOSIS INHIBITION; MODULATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER;

ARACHIDONATE 5-LIPOXYGENASE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENES, BCL-2; HUMANS; ISOENZYMES; LINOLEIC ACIDS, CONJUGATED; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 3242788087     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh116     Document Type: Article

References (34)

1. Eton,D.T. and Lepore,S.J. (2002) Prostate cancer and health-related quality of life: a review of the literature. Psychooncology, 11, 307-326.
2. DePinho,R.A. (2000) The age of cancer. Nature, 408, 248-254.
3. Hegarty,N.J., Fitzpatrick,J.M., Richie,J.P., Scardino,P.T., DeVere,R.W., Schröder,F.H. and Coffey,D.S. (1999) Future prospects in prostate cancer. Prostate, 40, 261-268.
4. Badawi,A.F. (2000) The role of prostaglandin synthesis in prostate cancer. BJU Int., 85, 451-462.
5. Kirschenbaum,A., Liu,X.-H., Yao,S. and Levine,A.C. (2001) The role of cyclooxygenase-2 in prostate cancer. Urology, 58, 127-131.
6. Steele,V.E., Holmes,C.A., Hawk,E.T., Kopelovick,L., Lubet,R.A., Crowell,J.A., Sigman,C.C. and Kelloff,G.J. (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev., 8, 467-483.
7. Evan,G.I. and Vousden,K.H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342-348.
8. Tapia-Vieyra,J.V. and Mas-Oliva,J. (2001) Apoptosis and death channels in prostate cancer. Arch. Med. Res., 32, 175-185.
9. McGarvey,T.W. and Malkowicz,B. (2000) Steady state expression of cell-cycle regulatory genes in prostate carcinoma cell lines. Urol. Oncol., 5, 71-77.
10. Clinton,S.K. and Giovannucci,E. (1998) Diet, nutrition and prostate cancer. Annu. Rev. Nutr., 18, 413-440.
11. Knowles,L.M., Zigrossi,D.A., Tauber,R.A., Hightower,C. and Milner,J.A. (2000) Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr. Cancer, 38, 116-122.
12. Brawley,O.W., Barnes,S. and Parnes,H. (2001) The future of prostate cancer prevention. Ann. N. Y. Acad. Sci., 952, 145-152.
13. Kolonel,L.N., Nomura,A.M.Y. and Cooney,R.V. (1999) Dietary fat and prostate cancer: current status. J. Natl Cancer Inst., 91, 414-428.
14. Whigham,L.D., Cook,M.E. and Atkinson,R.L. (2000) Conjugated linoleic acid: implications for human health. Pharmacol. Res., 42, 503-510.
15. Pariza,M.W., Park,Y. and Cook,M.E. (2001) The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res., 40, 283-298.
16. Kelly,G.S. (2001) Conjugated linoleic acid: a review. Altern. Med. Rev., 64, 367-382.
17. Wahle,K.W.J and Heys,S.D. (2002) Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis. Prostaglandins Leukot. Essent. Fatty Acids, 67, 183-186.
18. Cesano,A., Visonneau,S., Scimeca,J.A., Kritchevsky,D. and Santoli,D. (1998) Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res., 18, 833-838.
19. Palombo,J.D., Ganguly,A., Bistrian,B.R. and Menard,M.P. (2002) The antiproliferative effects of biologically active isomers of conjugated linolec acid on human colorectal and prostatic cancer cells. Cancer Lett., 177, 163-172.
20. Cohen,L.A., Zhao,Z., Pittman,B. and Scimeca,J. (2003) Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-I rat prostate tumors. Prostate, 54, 169-180.
21. 4]-chloride platinum (II) monohydrochloride monohydrate. Invest. New Drugs, 22, 3-16.
22. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
23. Yoshimura,R., Sano,H., Masuda,C., Kawamura,M., Tsubouchi,Y., Chargui,J., Yoshimura,N., Hla,T. and Wada,S. (2000) Expression of cyclooxygenase-2 in prostate carcinoma. Cancer, 89, 589-596.
24. Fujita,H., Koshida,K., Keller,E.T., Takahashi,Y., Yoshimito,T., Namiki,M. and Mizokami,A. (2002) Cyclooxygenase-2 promotes prostate cancer progression. Prostate, 53, 232-240.
25. Anderson,K.M., Seed,T., Vos,M., Mulshine,J., Meng,J., Alrefai,W., Ou,D. and Harris,J.E. (1998) 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death. Prostate, 37, 161-173.
26. Gupta,S., Srivastava,M., Ahmad,N., Sakamoto,K., Bostwitck,D.G. and Mukhtar,H. (2001) Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer, 91, 737-743.
27. Subbaramaiah,K., Zakim,D., Weksler,B.B. and Dannenberg,A.J. (1997) Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 201-210.
28. Miller,A., Stanton,C. and Devery,R. (2001) Modulation of arachidonic acid distribution by conjugated linoleic acid isomers and linoleic acid in MC-7 and SW480 cancer cells. Lipids, 36, 1161-1168.
29. Urquhart,P., Parkin,S.M., Rogers,J.S., Bosley,J.A. and Nicolaou,A. (2002) The effect of conjugated linoleic acid on arachidonic acid metabolism and iecosanoid production in human saphenous vein endothelial cells. Biochim. Biophys. Acta, 1580, 150-160.
30. Majumder,B., Wahle,K.W.J., Moir,S., Schofield,A., Choe,S., Farquharson,A., Grant,I. and Heys,S.D. (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J., 16, 1447-1449.
31. Catz,S.D. and Johnson,J.L. (2003) BCL-2 in prostate cancer: a mint-review. Apoptosis, 8, 29-37.
32. Dotto,G.P. (2000) p21WAF1/CIP1: more than a break to the cell cycle? Biochim. Biophys. Acta, 1471, 43-56.
33. Liang,J.-Y., Fontana,J.A., Rao,J.N., Ordonez,J.V., Dawson,M.I., Shroot,B., Wilber,J.F. and Feng,P. (1999) Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate, 38, 228-236.
34. WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation. Prostate, 51, 211-218.